Cardiac Shock Wave Therapy Ameliorates Myocardial Ischemia in Patients With Chronic Refractory Angina Pectoris: A

Liu Weijing1, Fan Ximin1, Shen Jianying1

  • 1Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.

Insights

Cardiac shock wave therapy (CSWT) offers a safe and effective non-invasive treatment for chronic refractory angina pectoris (CRAP). CSWT significantly improves patient symptoms and myocardial perfusion without adverse effects.

Area of Science:

  • Cardiology
  • Non-invasive therapies

Background:

  • Chronic refractory angina pectoris (CRAP) presents a significant clinical challenge.
  • Cardiac shock wave therapy (CSWT) is an emerging non-invasive treatment option.

Purpose of the Study:

  • To evaluate the safety and efficacy of CSWT in patients with CRAP.
  • To assess improvements in angina severity, quality of life, and myocardial perfusion.

Main Methods:

  • Eighty-seven CRAP patients were randomized into CSWT (n=46) and control (n=41) groups.
  • Evaluated Canadian Cardiovascular Society (CCS) grade, Seattle Angina Questionnaire (SAQ) score, 6-min walk test (6MWT), and D-SPECT myocardial perfusion.
  • Monitored adverse events throughout the study.

Main Results:

  • CSWT was well-tolerated, with no significant adverse events reported.
  • Significant improvements observed in CCS grade, SAQ score, and 6MWT in the CSWT group (p < 0.05).
  • Reduced ischemic areas on D-SPECT imaging post-CSWT, with no changes in the control group.

Conclusions:

  • CSWT demonstrates potential to improve myocardial perfusion and alleviate clinical symptoms in CRAP patients.
  • The therapy is safe and non-invasive, offering a viable treatment option for CRAP.
  • Further research supports CSWT as a promising therapeutic strategy for refractory angina.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
62
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
143
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
818
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
80
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
74
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
98